Optimize 1 Trial News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Optimize 1 Trial. Real-time updates on events, politics, business and more.

European Medicines Agency Grants Orphan Drug Designation to Mitazalimab for Pancreatic Cancer

August 26, 2023

The European Medicines Agency has granted orphan drug designation to mitazalimab for use in patients with pancreatic cancer.

Source: onclive.com

May 22, 2023

The FDA has granted an orphan drug designation to mitazalimab for use as a potential therapeutic option in patients with pancreatic cancer.

Source: onclive.com